GlassScriptPhysician profile
Jeffrey Truitt
NPI 1700066040
$1,330.10
in general payments reported to CMS, 2019-2025
17 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $136 · 2021: $312 · 2023: $109 · 2024: $434 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $758.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $537.44 | 2019-2025 | Octrode, Eterna, Proclaim |
| Nevro Corp. | $191.36 | 2021-2024 | Senza |
| Arbor Pharmaceuticals, INC. | $136.16 | 2021 | |
| Boston Scientific Corporation | $107.03 | 2019-2025 | General - Dbs |
| Scilex Pharmaceuticals INC. | $77.03 | 2019-2021 | |
| Lilly USA, LLC | $36.81 | 2025 | Kisunla |
| Medtronic USA, INC. | $35.69 | 2019 | |
| Azurity Pharmaceuticals, INC. | $24.79 | 2025 | Horizant |
| Alexion Pharmaceuticals, INC. | $24.51 | 2025 | Ultomiris |
| Vertex Pharmaceuticals Incorporated | $24.34 | 2024 | |
| Averitas Pharma INC. | $23.77 | 2024 | Qutenza |
| Grt US Holding, INC. | $20.67 | 2021 | |
| Kaleo, INC. | $19.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.88 | 2023 | Relistor |
| Abbvie INC. | $17.68 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $17.38 | 2019 | |
| Pfizer INC. | $16.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Truitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.